Position in REGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$42,732,400
+$16,643,194 QoQ
Shares Held
55,307
+63.6% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Jun 30, 2022CallValue
$0
CallShares
0
PutValue
$234,087
PutShares
396
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026NATIXIS holds $79,787,364 across 30 Biotechnology names. REGN ranks #1 (53.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
55,307 | $42,732,400 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
48,192 | $21,519,655 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
17,076 | $5,649,936 | |
| 4 | ERAS |
Erasca, Inc.
|
163,192 | $2,640,446 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
81,754 | $1,712,746 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
41,536 | $1,598,720 | |
| 7 | CAI |
Caris Life Sciences, Inc.
|
52,778 | $943,670 | |
| 8 | TECH |
BIO-TECHNE Corp
|
11,286 | $589,806 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42,732,400 | 55,307 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $26,089,206 | 33,800 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $35,865,516 | 63,787 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $37,894,500 | 72,180 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $44,033,954 | 69,429 | Shares | Sole | 2025-07-18 | |
| 2024-12-31 | $64,853,372 | 91,044 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $57,358,808 | 54,563 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $25,481,171 | 24,244 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,251,345 | 5,456 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $19,350,485 | 22,032 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $10,519,897 | 12,783 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,075,160 | 12,630 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,662,155 | 5,674 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $20,494,644 | 28,406 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $19,580,440 | 28,424 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $29,377,387 | 49,697 | Shares | Sole | 2022-08-12 | |
| 2022-06-30 | $234,087 | 396 | Put | Sole | 2022-08-12 | |
| 2022-03-31 | $92,099,946 | 131,869 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,403,988 | 18,058 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,893,362 | 13,043 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $12,644,666 | 26,725 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $12,250,220 | 25,357 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,738,864 | 10,252 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $79,824,081 | 127,995 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,378,008 | 8,966 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||